We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 30, 2023

Longitudinal Characterisation of B- and T-Cell Immune Responses After a Booster Dose of the COVID-19 mRNA Vaccine in People With MS on Different Disease-Modifying Therapies

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Journal of Neurology, Neurosurgery, and Psychiatry
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
J. Neurol. Neurosurg. Psychiatr. 2022 Dec 15;[EPub Ahead of Print], A Aiello, A Coppola, S Ruggieri, C Farroni, AMG Altera, A Salmi, V Vanini, G Cuzzi, L Petrone, S Meschi, D Lapa, A Bettini, S Haggiag, L Prosperini, S Galgani, ME Quartuccio, N Bevilacqua, AR Garbuglia, C Agrati, V Puro, C Tortorella, C Gasperini, E Nicastri, D Goletti

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading